Potential Opportunities of Modeling Bioavailability for Monoclonal Antibodies: An Overview of mAbs and the current challenges of mAb development
A. Kohli, O. Fayaz, A. Jensen, C. Chung, C. Korban
This paper reviews 10 monoclonal antibodies, analyzes their pharmacokinetic and pharmacodynamic properties, and uses a machine learning model to assess subcutaneous bioavailability and optimize drug delivery.
bioRxiv · Apr 14, 2024 · PreprintBioengineering